Analysts Viewpoint SXTP’s latest rating updates from top analysts. 60 Degrees Pharmaceuticals Inc’s recent filing unveils that its Director XU CHERYL acquired Company’s shares for reported $14410.0 on Jun
Stock Earnings 60 Degrees Pharmaceuticals Inc’s latest rating changes from various analysts 60 Degrees Pharmaceuticals Inc’s filing revealed that its Director XU CHERYL acquired Company’s shares for reported $14410.0 on Jun 03